Information Journal Paper
APA:
CopyGRAGOUDAS, E.S., ADAMIS, A.P., CUNNINGHAM, E.T. JR., FEINSOD, M., & GUYER, D.R.. (2004). VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. NEW ENGLAND JOURNAL OF MEDICINE (NEJM), 351(27), 2805-2816. SID. https://sid.ir/paper/550995/en
Vancouver:
CopyGRAGOUDAS E.S., ADAMIS A.P., CUNNINGHAM E.T. JR., FEINSOD M., GUYER D.R.. VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. NEW ENGLAND JOURNAL OF MEDICINE (NEJM)[Internet]. 2004;351(27):2805-2816. Available from: https://sid.ir/paper/550995/en
IEEE:
CopyE.S. GRAGOUDAS, A.P. ADAMIS, E.T. JR. CUNNINGHAM, M. FEINSOD, and D.R. GUYER, “VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,” NEW ENGLAND JOURNAL OF MEDICINE (NEJM), vol. 351, no. 27, pp. 2805–2816, 2004, [Online]. Available: https://sid.ir/paper/550995/en